Flaujeac trait. Deficiency of human plasma kininogen
- PMID: 127805
- PMCID: PMC333145
- DOI: 10.1172/JCI108248
Flaujeac trait. Deficiency of human plasma kininogen
Abstract
Flaujeac trait plasma resembled Hageman trait or Fletcher trait, in that the intrinsic coagulation pathway, plasma fibinolytic pathway, kinin-forming system, permeability factor of dilution (PF/dil) phenomenon were abnormal. The defect in each assay was reconstituted by afactor separable from Hageman factor or Fletcher factor. This substance was an alpha-globulin with an approximate mol wt of 170,000. Flaujeac plasma did not release a kinin upon incubation with kallikrein and was deficient in total kininogen antigen. Antiserum to kininogen inhibited the activity of the factor in solution. Flaufeac factor was identified as a kininogen of high molecular weight (HMW-kininogen). The mean total kininogen antigen in four children of the proposita was 51% (range 34-62%) of normal. A functional coagulation assay of HMW-kininogen in the children was 34% (range 23-55%). The results were consistent with autosomal recessive inheritance. The plasma pathways of intrinsic coagulation, fibrinolysis, kinin formation, and PF/dil generation are dependent upon HMW-kininogen. We believe this is the first demonstration of biological function for a kininogen apart from its role as a substrate for kallikreins.
Similar articles
-
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.J Clin Invest. 1975 Dec;56(6):1650-62. doi: 10.1172/JCI108247. J Clin Invest. 1975. PMID: 1202089 Free PMC article.
-
Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.J Clin Invest. 1976 Dec;58(6):1395-406. doi: 10.1172/JCI108595. J Clin Invest. 1976. PMID: 993350 Free PMC article.
-
Purification of high molecular weight kininogen and the role of this agent in blood coagulation.J Clin Invest. 1977 Sep;60(3):584-94. doi: 10.1172/JCI108810. J Clin Invest. 1977. PMID: 893664 Free PMC article.
-
The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.Crit Rev Immunol. 1981 Sep;3(1):75-93. Crit Rev Immunol. 1981. PMID: 7047077 Review.
-
Participation of Hageman factor dependent pathways in human disease states.Thromb Haemost. 1977 Dec 15;38(4):751-75. Thromb Haemost. 1977. PMID: 341410 Review.
Cited by
-
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.J Clin Invest. 1977 Jul;60(1):18-31. doi: 10.1172/JCI108754. J Clin Invest. 1977. PMID: 874082 Free PMC article.
-
Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.J Clin Invest. 1977 Sep;60(3):571-83. doi: 10.1172/JCI108809. J Clin Invest. 1977. PMID: 893663 Free PMC article.
-
Genetics of equine bleeding disorders.Equine Vet J. 2021 Jan;53(1):30-37. doi: 10.1111/evj.13290. Epub 2020 Jun 23. Equine Vet J. 2021. PMID: 32463964 Free PMC article. Review.
-
Guinea pig Hageman factor as a vascular permeability enhancement factor.Am J Pathol. 1981 Nov;105(2):164-75. Am J Pathol. 1981. PMID: 6794374 Free PMC article.
-
The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.J Clin Invest. 1977 Jun;59(6):1167-75. doi: 10.1172/JCI108741. J Clin Invest. 1977. PMID: 864009 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources